Livingstone has acted as strategic advisor to Steril Verona S.r.l. (“Steril Verona”), supporting the shareholders in a corporate reorganization process and in defining the financial and operational framework for the company’s future growth.
Founded in 1997, Steril Verona is a family-owned company specializing in ethylene oxide (EO) sterilization, serving leading manufacturers of medical devices, surgical instruments, and pharmaceutical packaging. The company operates three dedicated sterilization facilities in the province of Verona, covering a total area of approximately 17,000 sqm.
The advisory mandate focused on two key objectives: streamlining the ownership structure, following the exit of a shareholder and laying the foundations for a significant investment plan, aimed at increasing production capacity through the construction of a new sterilization facility.
“Supporting Steril Verona through this strategic engagement highlights the value of proactive planning in a rapidly evolving healthcare landscape,” said Umberto Rossi, Partner at Livingstone.
This assignment underscores Livingstone’s ability to support companies in the Healthcare sector not only through M&A transactions, but also via high-value strategic advisory, enabling businesses to realign governance and unlock long-term value.
